Combinatorial approach to hepadnavirus-like particle vaccine design - Wikidata - wikimedia - TriplyDB

Combinatorial approach to hepadnavirus-like particle vaccine design

Combinatorial approach to hepadnavirus-like particle vaccine design

http://www.wikidata.org/entity/Q34092773

about

Exploiting virus-like particles as innovative vaccines against emerging viral infections Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2 Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7 Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies.Comparative antigenicity and immunogenicity of hepadnavirus core proteins.Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype.Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections.Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms Hepatitis B virus nucleocapsid but not free core antigen controls viral clearance in mice.Virus-like particles: flexible platforms for vaccine development.Engineering virus-like particles as vaccine platforms Interaction of the hepatitis B core antigen and the innate immune system.Use of hepadnavirus core proteins as vaccine platforms.Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology.Review on the identification and role of Toxoplasma gondii antigenic epitopes.A bi-functional hepatitis B virus core antigen (HBcAg) chimera activates HBcAg-specific T cells and preS1-specific antibodies.Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection.Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide.Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display Vaccination

P2860

Q29365799-05AB6A35-174E-4A3E-B3D4-06EBB93550A0 Q33338311-5696A28A-76CB-4450-B16A-F81A310E9698 Q33569555-249A2031-B35E-41F5-9192-CCED64451940 Q33890011-F0165D7F-0A8F-4314-8C71-DCC3AB8DE59C Q34092768-6D93DC53-2A6A-4F5F-A09F-F231C12209F7 Q34126717-34A4F3B7-A7AF-44C0-93AE-1F569B8BC180 Q35535626-578AA5FC-8E72-4528-A8C5-B83D7872BF84 Q35561160-B4736A78-FE56-48FA-8281-98742E7F405A Q35591551-FC9DE0FF-CF00-4253-803A-6FFD52C16092 Q35663329-4B1B7FA5-FF88-4613-A1E4-EDDB71005CB8 Q36154923-27E9CCDA-2B57-4E9E-845A-301274A299FB Q36837144-A9C1AC94-8D28-4865-9293-EE41D5F04F07 Q37172342-D7BE5A67-9E59-4E0F-9B1F-EB1F772E2D13 Q37200526-B2A5811C-2C85-44BF-97B2-F9B0CAE2E907 Q37622906-CC98EA03-2B46-40AC-8211-920387535535 Q38554795-0832C637-163A-42E8-A198-F8F28FE39D7B Q38637651-EA817575-700F-46AD-92B8-4FAE7105B373 Q45363157-058CFAF1-88DA-4C3D-8533-D05412428B6B Q45417527-8E4B2464-504A-4401-9018-2085668124B5 Q52589518-B47C5B57-7FF0-471C-977A-80477DCA20AA Q56355788-3A36881C-7B71-433E-AFF9-597608C30207

P2860

Combinatorial approach to hepadnavirus-like particle vaccine design

http://www.wikidata.org/entity/Q34092773

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Combinatorial approach to hepadnavirus-like particle vaccine design

@ast

Combinatorial approach to hepadnavirus-like particle vaccine design

@en

Combinatorial approach to hepadnavirus-like particle vaccine design

@nl

type

label

Combinatorial approach to hepadnavirus-like particle vaccine design

@ast

Combinatorial approach to hepadnavirus-like particle vaccine design

@en

Combinatorial approach to hepadnavirus-like particle vaccine design

@nl

prefLabel

Combinatorial approach to hepadnavirus-like particle vaccine design

@ast

Combinatorial approach to hepadnavirus-like particle vaccine design

@en

Combinatorial approach to hepadnavirus-like particle vaccine design

@nl

P1433

Q34092773-5028F816-8513-49D8-9918-06FCCD5B893F

P1476

Q34092773-8AA9FBE5-FF52-40BF-9AA3-2DAFBD48240B

P2093

Q34092773-0502264E-A104-4D4D-A551-1FA3C5F24215

Q34092773-0A651990-1F3A-43FA-B355-B68EBC9E0777

Q34092773-39DA13ED-2AF2-4DE2-A356-0B06AD299811

Q34092773-3C6CAFAB-861F-4C05-B897-AB95B4BA3A5E

Q34092773-42AEF3CA-2EC2-47FC-96E0-93635ADAF7DA

Q34092773-A99AC88F-3E1C-475B-A523-DE6D8F8DC41C

Q34092773-AB2F5F3A-1384-4CA1-8CD2-42FA47AFE363

Q34092773-BF48C46B-CAEC-4C8C-8CF4-AD08C0A43B2C

Q34092773-C94B15DB-472F-4240-AF8B-62521740AC13

Q34092773-E4EB8F3B-0F31-45FF-9274-9DCEA01E0008

P2860

Q34092773-0065F162-FBEC-4BF7-8AB7-47D00E4262F5

Q34092773-083F16DA-3431-4514-A35B-1DF675A5F2C5

Q34092773-0DB32132-A7A0-4FFE-92FD-F2407D88C52A

Q34092773-1F8F272A-6426-465F-8C9D-64D8A8B5336D

Q34092773-240732B3-AF18-4805-B4C7-482332F62707

Q34092773-2799C693-54BE-461B-B3FE-9932A83FF68F

Q34092773-2A863E12-3FAA-4798-AFFE-0CE453D08449

Q34092773-326942C2-F190-4CAA-90C3-D3E7037BA162

Q34092773-3584A9D2-8693-477D-8255-107BBD4654CC

Q34092773-41FD3088-5221-4160-BCF4-CFBE00D6A7B3

P304

Q34092773-A4533BFD-77EC-4C0F-A8D8-9D8015C460D6

P31

Q34092773-6ADF4A04-B387-44A8-B4DF-9C7F0A2BF022

P356

Q34092773-B7C0192C-7E26-4C47-ADAD-A0A12CF43690

P407

Q34092773-FE40C61A-C2C2-480B-8C93-DB053B57CCCC

P433

Q34092773-4D655DF2-C33F-457A-B369-DF53D4E7D389

P478

Q34092773-2C3B3110-8D42-4FC7-98E3-7392A4CEC55D

P577

Q34092773-F1FE0E47-DB10-4737-B004-AC1BFB2F25FA

P698

Q34092773-A2616654-C238-4F81-9FE3-955B7249460D

P932

Q34092773-9815477E-0EB1-469A-8B77-6A0FAAF4127A

P356

JVI.79.21.13656-13666.2005

P1433

Journal of Virology

P1476

Combinatorial approach to hepadnavirus-like particle vaccine design

@en

P2093

Antony Chen

http://www.w3.org/2001/XMLSchema#string

Darrell Peterson

http://www.w3.org/2001/XMLSchema#string

David Milich

http://www.w3.org/2001/XMLSchema#string

Fermin Garduno

http://www.w3.org/2001/XMLSchema#string

Janice Hughes

http://www.w3.org/2001/XMLSchema#string

Jean-Noel Billaud

http://www.w3.org/2001/XMLSchema#string

Joyce Jones

http://www.w3.org/2001/XMLSchema#string

Margaret Barr

http://www.w3.org/2001/XMLSchema#string

Matti Sallberg

http://www.w3.org/2001/XMLSchema#string

Phillip Goldstein

http://www.w3.org/2001/XMLSchema#string

P2860

The crystal structure of the human hepatitis B virus capsid

Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein.

Comparative antigenicity and immunogenicity of hepadnavirus core proteins.

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses.

HBV core particles as a carrier for B cell/T cell epitopes.

Diversity of core antigen epitopes of hepatitis B virus

Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies.

Synthetic peptide vaccine confers protection against murine malaria.

Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes

The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.

P304

13656-13666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.79.21.13656-13666.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16227285

http://www.w3.org/2001/XMLSchema#string

P932

1262598

http://www.w3.org/2001/XMLSchema#string